Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Dracaena fragrans
Plante intérieure d'Afrique tropicale populaire avec des fleurs parfumées, utilisée en médecine traditionnelle africaine occidentale.
Popular tropical African houseplant with fragrant flowers, used in West African traditional medicine. This herb is with limited but promising clinical support. Key active compounds include saponins, dracaenins, flavonoids, tannins, which underpin its pharmacological activity across 6 documented traditional and modern indications.
saponins, along with dracaenins and flavonoids, and to a lesser extent tannins, represent the primary bioactive constituents of Dracaena fragrans. These compounds collectively modulates NF-κB, COX-2, and 5-LOX inflammatory cascades, reducing pro-inflammatory cytokine production; disrupts microbial cell membrane integrity and inhibits ATP synthesis in pathogens; promotes fibroblast proliferation, collagen deposition, and antimicrobial activity at wound sites, contributing to the herb's observed therapeutic effects.
Plante intérieure d'Afrique tropicale populaire avec des fleurs parfumées, utilisée en médecine traditionnelle africaine occidentale.
Popular tropical African houseplant with fragrant flowers, used in West African traditional medicine. This herb is with limited but promising clinical support. Key active compounds include saponins, dracaenins, flavonoids, tannins, which underpin its pharmacological activity across 6 documented traditional and modern indications.
saponins, along with dracaenins and flavonoids, and to a lesser extent tannins, represent the primary bioactive constituents of Dracaena fragrans. These compounds collectively modulates NF-κB, COX-2, and 5-LOX inflammatory cascades, reducing pro-inflammatory cytokine production; disrupts microbial cell membrane integrity and inhibits ATP synthesis in pathogens; promotes fibroblast proliferation, collagen deposition, and antimicrobial activity at wound sites, contributing to the herb's observed therapeutic effects.